About: Serological prevalence of canine respiratory coronavirus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Serological prevalence of canine respiratory coronavirus Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Serological prevalence of canine respiratory coronavirus
Creator	Brownlie, Joe Erles, Kerstin Priestnall, Simon Dubovi, Edward
Source	Elsevier; Medline; PMC
abstract	Canine respiratory coronavirus (CRCoV) has recently been detected in dogs; it is a group 2 coronavirus showing similarity to bovine coronavirus (BCoV) but is distinct from canine enteric coronavirus (CECoV). CRCoV may play an important role in canine infectious respiratory disease (CIRD) either by predisposing to further and potentially more serious viral and bacterial infections or possibly as a primary pathogen. The prevalence of serum antibodies to CRCoV, in a population of dogs in the south east of England, has been shown previously to be 30.1% on the first day of entry to a rehoming kennel [Erles, K., Toomey, C., Brooks, H.W., Brownlie, J., 2003. Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease. Virology 310, 216–223]. The purpose of this study was to establish the prevalence of CRCoV in the general canine population within as well as outside the UK. An ELISA, used to test for the presence of antibodies to CRCoV in canine serum samples, identified seropositive dogs in UK, USA, Canada, Republic of Ireland and Greece. The development of an ELISA based on CRCoV antigen and immunofluorescence assay are described here. 54.7% (547/1000) of North American and 36.0% (297/824) of United Kingdom dogs were seropositive for CRCoV. The age and geographical distribution of seropositive dogs was also assessed. The cross-reactivity demonstrated between CRCoV antibodies from different countries and a UK viral isolate suggests immunological similarity. The overall prevalence of this virus in both North America and the UK suggests that CRCoV has international significance and that further epidemiological studies are required.
has issue date	2006-06-15(xsd:dateTime)
bibo:doi	10.1016/j.vetmic.2006.02.008
bibo:pmid	16551493
has license	no-cc
sha1sum (hex)	b2f03fa138a63cfaabf42c0719bfc4ad937cfa62
schema:url	https://doi.org/10.1016/j.vetmic.2006.02.008
resource representing a document's title	Serological prevalence of canine respiratory coronavirus
has PubMed Central identifier	PMC7117349
has PubMed identifier	16551493
schema:publication	Vet Microbiol
resource representing a document's body	covid:b2f03fa138a63cfaabf42c0719bfc4ad937cfa62#body_text
is schema:about of	named entity 'DOGS' named entity 'HERE' named entity 'CANINE ENTERIC CORONAVIRUS' named entity '310' named entity 'PREDISPOSING' named entity 'SIMILARITY' covid:arg/b2f03fa138a63cfaabf42c0719bfc4ad937cfa62 named entity 'antibodies' named entity 'cross-reactivity' named entity 'serum samples' named entity 'bacterial infections' named entity 'pathogen' named entity 'seropositive' named entity 'epidemiological studies' named entity 'seropositive' named entity 'coronavirus' named entity 'CRCoV' named entity 'Virology' named entity 'H.W.' named entity 'seropositive' named entity 'immunofluorescence assay' named entity 'virus' named entity 'CRCoV' named entity 'United Kingdom' named entity 'protein' named entity 'serological' named entity 'seropositivity' named entity 'Optimax' named entity 'seropositive' named entity 'CDV' named entity 'Canada' named entity 'antibodies' named entity 'mycoplasmas' named entity 'interstitial pneumonitis' named entity 'dog' named entity 'cross-reactivity' named entity 'CRCoV' named entity 'New York' named entity 'CRCoV' named entity 'ROI' named entity 'Arizona' named entity 'biochemistry' named entity 'Northern Ireland' named entity 'Glasgow' named entity 'BCoV' named entity 'seroprevalence' named entity 'optical density' named entity 'antibodies' named entity 'antigen' named entity 'seropositive' named entity 'Devon' named entity 'East Anglia' named entity 'Wokingham' named entity 'canine' named entity 'supernatant' named entity 'Republic of Ireland' named entity 'CRCoV' named entity 'coronavirus' named entity 'pathogens' named entity 'serum' named entity 'PBS' named entity 'pet dogs' named entity 'canine' named entity 'ultraviolet' named entity 'virus' named entity 'BCoV' named entity 'CRCoV' named entity 'Rochester, NY' named entity 'infection' named entity 'respiratory disease' named entity 'coronavirus' named entity 'CRCoV' named entity 'haematological' named entity 'aetiologically' named entity 'England and Wales' named entity 'London' named entity 'seronegative' named entity 'gold standard'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software